US Patent

US8128960 — Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection

Formulation · Assigned to Alcon Research LLC · Expires 2029-12-17 · 4y remaining

Vulnerability score 53/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects low viscosity, highly flocculated triamcinolone acetonide suspensions suitable for intravitreal injection.

USPTO Abstract

Triamcinolone acetonide suspension compositions are disclosed. The suspension compositions have a relatively low viscosity and are easy to extrude through a 27- or 30-gauge needle but are highly flocculated and easily redispersed. The compositions are particularly suitable for intravitreal injection.

Drugs covered by this patent

triamcinolone-acetonide (TRIAMCINOLONE ACETONIDE)

Patent Metadata

Patent number: US8128960
Jurisdiction: US
Classification: Formulation
Expires: 2029-12-17
Drug substance claim: No
Drug product claim: Yes
Assignee: Alcon Research LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.